Biomarker Landscape Analysis: Unveiling Challenges and Opportunities Biomarkers are indicators of normal physiological and pathogenic processes, and/or responses to therapeutic interventions. They…Prashant SharmaMay 16, 2024 Read More
Going Digital: Emerging potential of Digital Biomarkers and AI/ML in Healthcare Digital biomarkers and AI/ML in healthcare are redefining how biomarker discovery, drug development, and personalized…Prashant SharmaMarch 29, 2024 Read More
GOBIOM’s biomarker database for enabling precision medicine Drug resistance and inadequate response to commonly administered drugs across different therapeutic indications poses a…Prashant SharmaApril 15, 2022 Read More
GOBIOM – understanding the platform’s utility in clinical research and drug development GOBIOM (Global Online Biomarker Database) is the world’s largest manually curated database of validated and…Prashant SharmaApril 15, 2022 Read More
Coronavirus clinical trials landscape – analysis using Excelra’s COVID-19 biomarker database The ongoing COVID-19 pandemic is continuing to spread rapidly across the globe. As of 30th…Prashant SharmaMarch 15, 2022 Read More
Pivotal role of biomarkers in diagnosing the ever changing landscape of COVID-19 infection The coronavirus (COVID-19) pandemic has proven to be a formidable scientific, medical, and social challenge.…Prashant SharmaDecember 16, 2020 Read More